Rothel J S, Boyle D B, Both G W, Pye A D, Waterkeyn J G, Wood P R, Lightowlers M W
University of Melbourne, Molecular Parasitology Laboratory, Werribee, Victoria, Australia.
Parasite Immunol. 1997 May;19(5):221-7. doi: 10.1046/j.1365-3024.1997.d01-200.x.
Sheep were immunized with a protective recombinant antigen (45W) from the cestode parasite Taenia ovis using three different vaccine delivery systems, either alone or in different combinations. The DNA encoding 45W was cloned into the expression plasmid pcDNA 3 and an ovine adenovirus to create nucleic acid and recombinant viral vector vaccines, respectively. Sheep received two vaccinations with various combinations of these two delivery systems and/or purified recombinant 45W protein in a conventional vaccine formulation containing Quil A as adjuvant (protein/Quil A vaccine). Sheep receiving two inoculations of either the nucleic acid or the recombinant adenovirus alone, demonstrated only low levels of 45W-specific antibody. However, immunization with either nucleic acid or recombinant adenovirus primed animals to mount an enhanced immune response after a subsequent vaccination with the protein/ Quil A vaccine. The most striking result was that sheep initially immunized with the nucleic acid vaccine and boosted with the recombinant adenovirus, mounted IgG1 responses > 65 fold higher than those of sheep receiving either vaccine alone. The level of antibody in these sheep was commensurate with that observed in animals vaccinated twice with the protein/Quil A adjuvanted vaccine. In both cases, host-protection from experimental challenge infection with T. ovis was obtained.
使用三种不同的疫苗递送系统,单独或组合使用,用来自绦虫寄生虫绵羊带绦虫的保护性重组抗原(45W)对绵羊进行免疫。将编码45W的DNA分别克隆到表达质粒pcDNA 3和绵羊腺病毒中,以分别制备核酸疫苗和重组病毒载体疫苗。绵羊接受了这两种递送系统的各种组合和/或含有Quil A作为佐剂的传统疫苗制剂中的纯化重组45W蛋白的两次疫苗接种(蛋白/Quil A疫苗)。单独接受核酸或重组腺病毒两次接种的绵羊,仅表现出低水平的45W特异性抗体。然而,用核酸或重组腺病毒免疫的动物在随后用蛋白/Quil A疫苗接种后引发了增强的免疫反应。最显著的结果是,最初用核酸疫苗免疫并用重组腺病毒加强免疫的绵羊,其IgG1反应比单独接受任何一种疫苗的绵羊高出65倍以上。这些绵羊中的抗体水平与用蛋白/Quil A佐剂疫苗接种两次的动物中观察到的水平相当。在这两种情况下,均获得了针对绵羊带绦虫实验性攻击感染的宿主保护。